Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 50.33
-0.16 (-0.32%)
May 15, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Biological Products | 2.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biological Products Growth | 58.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Equipment and Others | 148.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Equipment and Others Growth | 60.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Franchise Service | 99.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Franchise Service Growth | -26.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Xiulin Pen and Component | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Xiulin Pen and Component Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| China | 2.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 51.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 425.98M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 54.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central and South America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central and South America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|